Skip to main content
. 2022 Apr 18;23(8):4441. doi: 10.3390/ijms23084441

Figure 3.

Figure 3

The number of tracked mutations impacts the ctDNA detection rate. Overview of MRD testing, including why tracking many mutations is important, particularly when there is a low fraction of cancerous cfDNA in the bloodstream. (A) Tumor tissue is available; (B) Tumor tissue is not available. WES, whole-exome sequencing. Created with BioRender.com.